Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Blinded, Controlled Trial of a Third Dose of Moderna COVID-19 Vaccine Versus Placebo in Solid Organ Transplant Recipients

NCT04885907 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04885907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04885907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Blinded, Controlled Trial of a Third Dose of Moderna COVID-19 Vaccine Versus Placebo in Solid Organ Transplant Recipients
Lead sponsor
University Health Network, Toronto
Phase
Phase 4
Overall status
Completed
Start date
May 25, 2021
Completion date
August 30, 2021
Enrollment
120 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, immune suppression, vaccine response impaired